KRAS and neoplasm: In some non-KRAS-dependent cells, even when KRAS was completely inhibited, the cells were still viable, indicating that the resistance of some KRAS G12C-mutated tumours to G12C inhibitors is due to the low dependence of cells on KRAS [36].